Autopsy report · NCT00974740

DIATOR-Diabetes Intervention With Atorvastatin

“for lack of recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 6 months after it had already started.
• Ran for about 5 years before it stopped.
• 63 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Profil Institut für Stoffwechselforschung GmbH

Sponsor type

Industry

Conditions

Type 1 Diabetes

Interventions

Atorvastatin; atorvastatin matching placebo

Participants

63

Sites

12

Countries

Germany

Trials that died the same way

• Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
  “due to lack of recruitment” (87% match in meaning)
• Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
  “lack of recruitment.” (87% match in meaning)
• REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia
  “Because of low recruitment” (85% match in meaning)
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.